Mavyret Interactions
There are 195 drugs known to interact with Mavyret (glecaprevir/pibrentasvir), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 29 are major, 161 are moderate, and 5 are minor.
- View all 195 medications that may interact with Mavyret
- View Mavyret alcohol/food interactions (1)
- View Mavyret disease interactions (2)
Most frequently checked interactions
View interaction reports for Mavyret (glecaprevir / pibrentasvir) and the medicines listed below.
- amitriptyline
- amlodipine
- atorvastatin
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bupropion
- buspirone
- clonidine
- cyclobenzaprine
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Epclusa (sofosbuvir / velpatasvir)
- fluoxetine
- gabapentin
- Harvoni (ledipasvir / sofosbuvir)
- hydroxyzine
- Klonopin (clonazepam)
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- metformin
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- pantoprazole
- prednisone
- Suboxone (buprenorphine / naloxone)
- tramadol
- trazodone
- Vraylar (cariprazine)
- Wellbutrin XL (bupropion)
Mavyret alcohol/food interactions
There is 1 alcohol/food interaction with Mavyret (glecaprevir / pibrentasvir).
Mavyret disease interactions
There are 2 disease interactions with Mavyret (glecaprevir / pibrentasvir) which include:
More about Mavyret (glecaprevir / pibrentasvir)
- Mavyret consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (424)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.